Cargando…

Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions

BACKGROUND: Government policy has precipitated recent changes in the provision of harm reduction interventions – injecting equipment provision (IEP) and opiate substitution therapy (OST) – for people who inject drugs (PWID) in Scotland. We sought to examine the potential impact of these changes on h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmateer, Norah E., Taylor, Avril, Goldberg, David J., Munro, Alison, Aitken, Celia, Shepherd, Samantha J., McAllister, Georgina, Gunson, Rory, Hutchinson, Sharon J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128763/ https://www.ncbi.nlm.nih.gov/pubmed/25110927 http://dx.doi.org/10.1371/journal.pone.0104515

Ejemplares similares

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review
por: Gillies, Michelle, et al.
Publicado: (2010)

Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs
por: Trayner, Kirsten M.A., et al.
Publicado: (2020)

Prevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort
por: Shepherd, Samantha J., et al.
Publicado: (2015)

High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs
por: Trayner, Kirsten M.A., et al.
Publicado: (2021)

Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs
por: Yeung, Alan, et al.
Publicado: (2022)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
por: Platt, Lucy, et al.
Publicado: (2017)

Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study
por: Trayner, Kirsten M.A., et al.
Publicado: (2022)

Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?
por: Ward, Zoe, et al.
Publicado: (2018)

When self-harm is about preventing harm: emergency management of obsessive–compulsive disorder and associated self-harm
por: Palombini, Erika, et al.
Publicado: (2021)

HIV positive patient with GBS-like syndrome
por: Shepherd, Samantha J., et al.
Publicado: (2017)

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
por: Martin, Natasha K, et al.
Publicado: (2013)

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
por: Martin, Natasha K., et al.
Publicado: (2013)

Average Household Exposure to Newspaper Coverage about the Harmful Effects of Hormone Therapy and Population-Based Declines in Hormone Therapy Use
por: Haas, Jennifer S., et al.
Publicado: (2007)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
por: Martin, Natasha K., et al.
Publicado: (2016)

Prevalence and determinants of hepatitis C virus infection among female drug injecting sex workers in Glasgow
por: Taylor, Avril, et al.
Publicado: (2008)

Cost-Effectiveness of HBV and HCV Screening Strategies – A Systematic Review of Existing Modelling Techniques
por: Geue, Claudia, et al.
Publicado: (2015)

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates
por: Lens, Sabela, et al.
Publicado: (2022)

Integrating patient and whole-genome sequencing data to provide insights into the epidemiology of seasonal influenza A(H3N2) viruses
por: Goldstein, Emily J., et al.
Publicado: (2017)

Northern Ireland Critical Care Incident Monitoring Study
por: Hutchinson, A, et al.
Publicado: (2008)

Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland
por: Prevost, Teresa C., et al.
Publicado: (2015)

Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified
por: Anderson, John E., et al.
Publicado: (2020)

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy
por: Auma, Ann W N, et al.
Publicado: (2021)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
por: McKeigue, Paul M, et al.
Publicado: (2022)

Differentiating adults who think about self-harm from those who engage in self-harm: the role of volitional alcohol factors
por: Melson, Ambrose J., et al.
Publicado: (2019)

Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom?
por: Garvey, Lucy J, et al.
Publicado: (2020)

HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination
por: Valencia La Rosa, Jorge, et al.
Publicado: (2018)

Infections with Spore-forming Bacteria in Persons Who Inject Drugs, 2000–2009
por: Palmateer, Norah E., et al.
Publicado: (2013)

The development of a multiplex real-time RT-PCR for the detection of adenovirus, astrovirus, rotavirus and sapovirus from stool samples
por: Bennett, Susan, et al.
Publicado: (2017)

Canada's System of Liability Coverage in the Event of Medical Harm: Is It Time for No-Fault Reform?
por: Lee, Shoo K., et al.
Publicado: (2021)

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy
por: Pérez-Is, Laura, et al.
Publicado: (2022)

During the summer 2009 outbreak of "swine flu" in Scotland what respiratory pathogens were diagnosed as H1N1/2009?
por: Gunson, Rory N, et al.
Publicado: (2011)

Modeling the Initiation of Others Into Injection Drug Use, Using Data From 2,500 Injectors Surveyed in Scotland During 2008–2009
por: White, Simon R., et al.
Publicado: (2015)

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

Harmful and Potentially Harmful Constituents in the Filler and Smoke of Tobacco-Containing Tobacco Products
por: Cheng, Tianrong, et al.
Publicado: (2022)

Hepatitis C viral load in HCV-monoinfected and HCV/HIV-1-, HCV/HTLV-1/-2-, and HCV/HIV/HTLV-1/-2-co-infected patients from São Paulo, Brazil
por: Alves, Fabiana Aparecida, et al.
Publicado: (2018)

Sobering evidence that higher taxes will mitigate alcohol-related cancer harms
por: Finucane, Francis M., et al.
Publicado: (2021)

Proteolytic enzymes in adenocarcinomata of the human colon.
por: Goldberg, D. M., et al.
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_mv71gim2fu62dhr85lnduegpcq